Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasms; Peptides, Cyclic; Receptor, EphA2; Oligopeptides; Maximum Tolerated Dose; Dose-Response Relationship, Drug; Adult; Aged; Aged, 80 and over; Middle Aged; Female
- PubMed ID
- 39231383
- Added to directory
- Source checked